ARCHIVES

In Brief: Oldham To Head Biological Response Modifiers Program; Walter, Namovicz Named Acting Heads

This article is from The Cancer Letter archive.

Vol. 06 No. 32 | August 8, 1980

Download PDF Visit The Full Archive

Related Articles

FDA Approves Bexxar For Non-Hodgkin’s Lymphoma

June 27, 2003

NCI Advisors Approve $100M Set Aside for Physical Sciences-Oncology Centers.

December 12, 2008

Aphton To Test Anti-Gastrin Drug At M. D. Anderson. NAS

March 31, 2000

White House To Appoint Richard Klausner, Molecular Biologist, As NCI’s 11th Director

July 28, 1995

Transplant Is Viable Option For HIV+ Patients, Study Finds

February 25, 2005

Eugenia Calle, 57, ACS Epidemiologist, Found Dead at Home; Murder Suspect Arrested

February 20, 2009